Antihistamines, Amantadine and Evolution of COVID-19
Antihistamines, Amantadine and Evolution of COVID-19
Recruiting · NCT05504057 · Registry updated 2026-04-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Antihistamines, Amantadine and Evolution of COVID-19 | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Not stated | 2026-04-03 | NCT05504057 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Consorci Sanitari de Terrassa | 21 |
| Institut Català de la Salut | 9 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital de Terrassa | Terrassa | Spain | 3 |
| Hospital of Terrassa | Terrassa | Spain | 1 |